A 3D quantitative imaging biomarker in pre-treatment MRI predicts overall survival after stereotactic radiation therapy of patients with a singular brain metastasis

Acta Radiol. 2019 Nov;60(11):1496-1503. doi: 10.1177/0284185119831692. Epub 2019 Mar 6.

Authors

Marta Della Seta¹, Federico Collettini^{1

2}, Julius Chapiro³, Alexander Angelidis⁴, Fidelis Engeling⁴, Bernd Hamm¹, David Kaul⁴

Affiliations

¹ Department of Radiology, Charité - University Medicine, Berlin, Germany.
² Berlin Institute of Health (BIH), Berlin, Germany.
³ Department of Radiology, Yale University, New Haven, CT, USA.
⁴ Department of Radiation Oncology, Charité - University Medicine, Berlin, Germany.

PMID: 30841703
DOI: 10.1177/0284185119831692

No abstract available

Keywords: Brain metastases; prognostic indices; radiomics.

Publication types

Evaluation Study

MeSH terms

Biomarkers
Brain / diagnostic imaging
Brain / radiation effects
Brain Neoplasms / diagnostic imaging*
Brain Neoplasms / radiotherapy*
Brain Neoplasms / secondary
Contrast Media
Evaluation Studies as Topic
Female
Humans
Image Enhancement / methods
Imaging, Three-Dimensional / methods*
Magnetic Resonance Imaging / methods*
Male
Middle Aged
Predictive Value of Tests
Radiosurgery / methods*
Retrospective Studies
Survival Analysis

Substances

Biomarkers
Contrast Media